Would you shut up. You sound like a moron on here. Literally. Let’s face it. KRAS is a loser in the onc treatment world.His bad toupee must go too.
Mirati Therapeutics (NASDAQ:MRTX) shareholders have endured a 57% loss from investing in the stock three years ago
Mirati Therapeutics (NASDAQ:MRTX) shareholders have endured a 57% loss from investing in the stock three years ago
If you love investing in stocks you're bound to buy some losers. Long term Mirati Therapeutics, Inc.(NASDAQ:MRTX) shareholders know that all too well, since the share price is down considerably over three years. Regrettably, they have had to cope with a 57% drop in the share price over that period. The more recent news is of little comfort, with the share price down 52% in a year. Unfortunately the share price momentum is still quite negative, with prices down 9.1% in thirty days.
LMAO. Q1 results.
Gee, a whole $71K in quarterly sales growth YoY. Pinch me.
You must go you stupid repeating tard.Meek and his bad toupee must go.
Meek must go.
What about the bad toupee?
I see the tard boy responded just three minutes after my earlier text four days ago. You obviously have a zero life and your monotonous ramblings indicate you’re a very sick man.Meek must go.
The toupee can stay on as the interim CEO, but Meek has got to go!
Does the toupee get stock options?
This company is all fugazi. The FDA will pull the drug. It is already toxic AF